Distinguished guests, ladies and gentlemen,
Good morning!
Before I begin, I would like to extend a warm welcome to the delegation from the Southern Taiwan Science Park Bureau, led by Deputy Director 林秀貞 and her outstanding team. It is a great honor to be here today at the Australia-Taiwan Biotechnology Forum. This event represents an important opportunity to strengthen our strategic partnership in biotechnology—a field that is vital for both Taiwan and Australia.
Both Taiwan and Australia shared a strong commitment to innovation and healthcare. Over the years, we have built solid foundations in research and development, which position us to effectively address global health challenges. This forum serves as a unique platform for exploring new collaboration opportunities.
Taiwan excels in areas like regenerative medicine, biopharmaceutical manufacturing, and digital health solutions. These strengths align perfectly with Australia’s expertise in clinical trials and biomedical research. Together, we have the potential to create groundbreaking advancements that can reshape healthcare and benefit the world.
A key example of our collaboration is in immunotherapy and vaccine development. Joint projects in these fields have already shown promising results in tackling health challenges such as cancer and infectious diseases. These achievements highlight the power of our partnership and set the stage for future innovations.
Precision medicine is another area ripe for collaboration. By combining Taiwan’s biopharma expertise with Australia’s world-class clinical trial networks, we can accelerate the development of personalized treatments, bringing life-saving solutions to patients more quickly.
In Taiwan, our legislative progress in regenerative medicine has been substantial, with the passage of two new laws this year. Our President William Lai has clearly expressed Taiwan's vision to make biotechnology and medical industries the next trillion-dollar sectors through regenerative medicine advancement. This is an exciting time, and we welcome Australia’s collaboration in this transformational journey.
Furthermore, we must focus on sustainable and inclusive innovation. Both Taiwan and Australia are dedicated to ensuring that our biotechnological advancements are accessible to all communities. This commitment is essential in addressing the global healthcare challenges that affect everyone.
As we look to the future, I encourage all of you to enthusiastically engage in cross-border collaborations—whether through research partnerships or talent exchanges. Together, we can build a vibrant biotech ecosystem that not only supports our nations but also contributes to global health.
Thank you for your dedication and hard work in advancing the Taiwan-Australia partnership through biotechnology. I am confident that by working hand in hand, we will make meaningful contributions to the global health landscape.
Wishing all of you a successful forum! Thank you very much!
